Clinical Trials Update: Jan. 27, 2011
Psoriasis Schizophrenia Type 2 Diabetes
(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:
This study of an investigational drug is for people who are getting inadequate relief from current psoriasis medication.
The research site is in Birmingham, Ala.
This study of an investigational drug will evaluate its ability to improve thinking skills -- such as focusing, remembering, and problem solving -- in people with schizophrenia. Participants will continue taking existing medication while receiving the study drug.
The research site is in Fresh Meadows, N.Y.
Type 2 Diabetes
This study is for people aged 18 to 65 who have type 2 diabetes. Participants will receive study-related care, study-related health assessments and study medication at no cost.
The research site is in Vancouver, Wash.
Copyright 2011 ClinicalConnection.com. All rights reserved.